Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Nishida

Showing results (131-140 of 164) with videos related to

Pageof 17
Sort By:
Blood Advances|March 14, 2025
Impact of Haplo-Donor Age on Transplant Outcomes: A Comparative Analysis of Haploidentical vs Cord Blood TransplantationTakashi Nagayama, Shin-Ichiro Fujiwara, Satoshi Nishiwaki, et al.
Cytotherapy|December 18, 2023
Impact of stem cell selection between bone marrow and peripheral blood stem cells for unrelated hematopoietic stem cell transplantation for hematologic malignancies: on behalf of the Donor/Source Working Group of the Japanese Society for Transplantation and Cellular TherapyHiromi Hayashi, Makoto Iwasaki, Hideki Nakasone, et al.
Journal of Dental Sciences|July 5, 2023
Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, JapanMasanori Nashi, Hiromitsu Kishimoto, Masaki Kobayashi, et al.
Bone Marrow Transplantation|April 4, 2025
Association of FLT3-ITD and NPM1 mutations with outcomes of allogeneic hematopoietic cell transplantation in acute myeloid leukemiaMasamitsu Yanada, Satoshi Yamasaki, Hiroki Hosoi, et al.
Bone Marrow Transplantation|April 16, 2025
The impact of the SARS-CoV-2 pandemic on umbilical cord blood transplantation in Japan: insights from an interrupted time series analysisNobuhiko Nakamura, Tetsuji Morishita, Hiromi Hayashi, et al.
Transplantation and Cellular Therapy|April 30, 2025
Heterogeneity of Survival Benefit Conferred By LetermovirYu Akahoshi, Hideki Nakasone, Katsuto Takenaka, et al.
Bone Marrow Transplantation|January 21, 2025
Myeloablative conditioning in cord blood transplantation for acute myeloid leukemia patients is efficacious only until age 55Shinichiro Oshima, Yasuyuki Arai, Tadakazu Kondo, et al.
Blood|September 2, 2017
Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDSIsao Tawara, Shinichi Kageyama, Yoshihiro Miyahara, et al.
Bone Marrow Transplantation|May 25, 2024
Association between human herpesvirus-6 encephalitis and antiviral prophylaxis after allogeneic hematopoietic stem cell transplantation in the letermovir eraToshiki Terao, Ken-Ichi Matsuoka, Shigeo Fuji, et al.
Transplantation and Cellular Therapy|May 28, 2026
The impact of female-to-male allogeneic hematopoietic cell transplantation on survival outcomes varies by recipient ageKosuke Takano, Masaharu Tamaki, Yoshitaka Inoue, et al.
Pageof 17

Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
Blood Advances|March 14, 2025
Impact of Haplo-Donor Age on Transplant Outcomes: A Comparative Analysis of Haploidentical vs Cord Blood TransplantationTakashi Nagayama, Shin-Ichiro Fujiwara, Satoshi Nishiwaki, et al.
Cytotherapy|December 18, 2023
Impact of stem cell selection between bone marrow and peripheral blood stem cells for unrelated hematopoietic stem cell transplantation for hematologic malignancies: on behalf of the Donor/Source Working Group of the Japanese Society for Transplantation and Cellular TherapyHiromi Hayashi, Makoto Iwasaki, Hideki Nakasone, et al.
Journal of Dental Sciences|July 5, 2023
Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, JapanMasanori Nashi, Hiromitsu Kishimoto, Masaki Kobayashi, et al.
Bone Marrow Transplantation|April 4, 2025
Association of FLT3-ITD and NPM1 mutations with outcomes of allogeneic hematopoietic cell transplantation in acute myeloid leukemiaMasamitsu Yanada, Satoshi Yamasaki, Hiroki Hosoi, et al.
Bone Marrow Transplantation|April 16, 2025
The impact of the SARS-CoV-2 pandemic on umbilical cord blood transplantation in Japan: insights from an interrupted time series analysisNobuhiko Nakamura, Tetsuji Morishita, Hiromi Hayashi, et al.
Transplantation and Cellular Therapy|April 30, 2025
Heterogeneity of Survival Benefit Conferred By LetermovirYu Akahoshi, Hideki Nakasone, Katsuto Takenaka, et al.
Bone Marrow Transplantation|January 21, 2025
Myeloablative conditioning in cord blood transplantation for acute myeloid leukemia patients is efficacious only until age 55Shinichiro Oshima, Yasuyuki Arai, Tadakazu Kondo, et al.
Blood|September 2, 2017
Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDSIsao Tawara, Shinichi Kageyama, Yoshihiro Miyahara, et al.
Bone Marrow Transplantation|May 25, 2024
Association between human herpesvirus-6 encephalitis and antiviral prophylaxis after allogeneic hematopoietic stem cell transplantation in the letermovir eraToshiki Terao, Ken-Ichi Matsuoka, Shigeo Fuji, et al.
Transplantation and Cellular Therapy|May 28, 2026
The impact of female-to-male allogeneic hematopoietic cell transplantation on survival outcomes varies by recipient ageKosuke Takano, Masaharu Tamaki, Yoshitaka Inoue, et al.
Pageof 17